Public signalCompany raiseAuto-indexed · Unverified
Cascade Biocatalysts, Inc. raised $5.4M
Cascade Biocatalysts, Inc.· DENVER, US· Biotechnology· Filed Aug 25, 2025
Cascade Biocatalysts, Inc. reported raising capital. Based in DENVER, COLORADO, US. First sale reported 2025-08-08. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$5.4M
Confidence90%
Raised
$5.4M
Investors
41
Incorporated
2022
Jurisdiction
DELAWARE
On the record
- Location
- DENVER, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $5.4M
- Target amount
- $5.6M
- Filing date
- Aug 25, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2022
- Industry group
- Biotechnology
- Number of investors
- 41
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $5.6M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 5,441,785 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Aug 25, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with Cascade Biocatalysts, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record